Atlas Trials

Central Nervous System Tumor, Pediatric

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Central Nervous System Tumor, Pediatric

RecordFirmDate
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors (NCT03638167)Seattle Children's Hospital2019-03-19
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors (NCT03500991)Seattle Children's Hospital2018-07-26
The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors (NCT02050243)Tel-Aviv Sourasky Medical Center2014-02-01
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy (NCT01346267)University of South Florida2011-05-01
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy (NCT01348607)University of South Florida2010-07-01
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer (NCT00357500)Dana-Farber Cancer Institute2005-01-01
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT (NCT00084838)Dana-Farber Cancer Institute2003-02-01
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma (NCT00098865)Dana-Farber Cancer Institute2002-09-01

Track Central Nervous System Tumor, Pediatric automatically

Every clearance here is in the API, with alerts when new ones post.